CH640865A5 - Glykoproteid des menschlichen urins, verfahren zu seiner herstellung und mittel zur bekaempfung von leukozytopenie. - Google Patents

Glykoproteid des menschlichen urins, verfahren zu seiner herstellung und mittel zur bekaempfung von leukozytopenie. Download PDF

Info

Publication number
CH640865A5
CH640865A5 CH254879A CH254879A CH640865A5 CH 640865 A5 CH640865 A5 CH 640865A5 CH 254879 A CH254879 A CH 254879A CH 254879 A CH254879 A CH 254879A CH 640865 A5 CH640865 A5 CH 640865A5
Authority
CH
Switzerland
Prior art keywords
glycoproteid
solution
hgi
aqueous solution
per
Prior art date
Application number
CH254879A
Other languages
German (de)
English (en)
Inventor
Fumimaro Takaku
Katsuhiro Ogasa
Morio Kuboyama
Minoru Saito
Nobuya Yanai
Masayuki Nishida
Satoshi Funakoshi
Muneo Yamada
Original Assignee
Morinaga Milk Industry Co Ltd
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53031999A external-priority patent/JPS6030291B2/ja
Priority claimed from JP53080695A external-priority patent/JPS6030293B2/ja
Priority claimed from JP53080694A external-priority patent/JPS6030292B2/ja
Priority claimed from JP53118203A external-priority patent/JPS6030294B2/ja
Application filed by Morinaga Milk Industry Co Ltd, Green Cross Corp filed Critical Morinaga Milk Industry Co Ltd
Publication of CH640865A5 publication Critical patent/CH640865A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61L2103/05—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH254879A 1978-03-20 1979-03-19 Glykoproteid des menschlichen urins, verfahren zu seiner herstellung und mittel zur bekaempfung von leukozytopenie. CH640865A5 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP53031999A JPS6030291B2 (ja) 1978-03-20 1978-03-20 人顆粒球の分化増殖を促進するｈｇｉ糖蛋白質、ｈｇｉ糖蛋白質の製造法及びｈｇｉ糖蛋白質を含有する白血球減少症治療剤
JP53080695A JPS6030293B2 (ja) 1978-07-03 1978-07-03 人顆粒球の分化増殖を促進する加熱処理ｈｇｉｇｐ及びｈｇｉｇｐの加熱処理方法
JP53080694A JPS6030292B2 (ja) 1978-07-03 1978-07-03 人顆粒球の分化増殖を促進する加熱処理ｈｇｉｇｐ及びｈｇｉｇｐの加熱処理法
JP53118203A JPS6030294B2 (ja) 1978-09-26 1978-09-26 人顆粒球の分化増殖を促進する糖蛋白質を含有する分画の加熱処理方法

Publications (1)

Publication Number Publication Date
CH640865A5 true CH640865A5 (de) 1984-01-31

Family

ID=27459534

Family Applications (1)

Application Number Title Priority Date Filing Date
CH254879A CH640865A5 (de) 1978-03-20 1979-03-19 Glykoproteid des menschlichen urins, verfahren zu seiner herstellung und mittel zur bekaempfung von leukozytopenie.

Country Status (8)

Country Link
AT (1) AT362392B (cg-RX-API-DMAC10.html)
AU (1) AU523077B2 (cg-RX-API-DMAC10.html)
CH (1) CH640865A5 (cg-RX-API-DMAC10.html)
DE (1) DE2910745A1 (cg-RX-API-DMAC10.html)
FR (1) FR2420541A1 (cg-RX-API-DMAC10.html)
GB (1) GB2016477B (cg-RX-API-DMAC10.html)
NL (1) NL190759C (cg-RX-API-DMAC10.html)
SE (1) SE451844B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342828A (en) * 1979-07-20 1982-08-03 Morinaga Milk Industry Co., Ltd. Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
JPS57144225A (en) * 1981-03-04 1982-09-06 Tadao Kokubu Antigenetic preparation for treating nonspecific allergic diseases and its preparation
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
AU589731B2 (en) * 1985-11-27 1989-10-19 Genetics Institute, Llc Colony stimulating factor for the treatment of aids-type diseases
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor

Also Published As

Publication number Publication date
AT362392B (de) 1981-05-11
NL190759B (nl) 1994-03-01
NL190759C (nl) 1994-08-01
SE451844B (sv) 1987-11-02
FR2420541A1 (fr) 1979-10-19
GB2016477A (en) 1979-09-26
ATA208479A (de) 1980-10-15
NL7902178A (nl) 1979-09-24
DE2910745C2 (cg-RX-API-DMAC10.html) 1988-06-23
DE2910745A1 (de) 1979-10-04
AU4519779A (en) 1979-09-27
FR2420541B1 (cg-RX-API-DMAC10.html) 1983-05-06
AU523077B2 (en) 1982-07-08
GB2016477B (en) 1982-08-25
SE7902372L (cg-RX-API-DMAC10.html) 1979-09-21

Similar Documents

Publication Publication Date Title
US4230697A (en) Virus-inactivated HGI-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
DE3027105C2 (cg-RX-API-DMAC10.html)
DE3402647C2 (de) Verfahren zur Gewinnung von koloniestimulierendem Faktor und Kallikrein aus menschlichem Urin
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
EP0457370B1 (de) Verfahren zur Pasteurisierung des Gewebeproteins PP4
DE3421789C2 (cg-RX-API-DMAC10.html)
EP0101063B1 (de) Neues Polypeptid mit Wirkung auf das Immunsystem, Verfahren zu seiner Isolierung und Reinigung, seine Verwendung und dieses enthaltende Mittel
DE68908426T2 (de) Adjuvanz für Krebsimmuntherapie.
DE2301501A1 (de) Verfahren zur gewinnung eines stabilen, von hypotensiven stoffen freien plasmaproteins
DE2910745C2 (cg-RX-API-DMAC10.html)
DE2825464A1 (de) Biologisch aktive substanz, verfahren zu deren herstellung und dieselbe enthaltendes pharmazeutisches mittel
DE2742150A1 (de) Verfahren zur herstellung von serumalbumin
DE69101784T2 (de) Stabilisierte zusammensetzung enthaltend ein fibroblastwachstumsfaktor.
EP0420049B1 (de) Stabilisierte Leukocyten-Interferone
DE3238620A1 (de) Stabile, nicht-blutdrucksenkende human-plasmaprotein-fraktion und verfahren zu deren herstellung
DE69836315T2 (de) Verwendung von TCF-II zur Behandlung von durch Krebs verursachtem Gewichtsverlust, Anaemie und TNF-Erhöhung
DE3914354C1 (cg-RX-API-DMAC10.html)
DE2558537C2 (de) Verfahren zum Isolieren von Substanzen mit insulinähnlicher Wirksamkeit aus Blut oder Blutbestandteilen von Kälbern oder Schweinen
DE3750248T2 (de) Zubereitung und Behandlung der Haut mit Human-Leukocyten-Interferon.
AT392003B (de) Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat
CH640244A5 (en) Biologically active substance
DE2409650C3 (de) Verwendung wäßriger Lösung von menschlichem Serum-Haptoglobin bei der Bekämpfung von hämolytischen Nierenstörungen
DE2720041A1 (de) Herzstaerkendes mittel
DE19921027A1 (de) Verbindungen mit antibiotischer Wirkung
DE2702075C2 (de) Hydrolytisches Enzym und dieses enthaltendes Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased